BioCentury
ARTICLE | Company News

Eisai, Institut Paoli-Calmettes deal

November 23, 2015 8:00 AM UTC

Eisai and the non-profit partnered to develop cancer targets and therapies. IPC will perform virtual chemo-informatic screening of Eisai’s chemical library to identify and evaluate protein-protein inh...